BiotechTube
Home/ARC Therapies/鈴木 蘭美 (Ranmi Suzuki)
鈴蘭

鈴木 蘭美 (Ranmi Suzuki)

CEO, Representative Director, President

ARC Therapies

Therapeutic Areas

Oncology

ARC Therapies Pipeline

DrugIndicationPhase
ATLL Cell TherapyAdult T-cell Leukemia/Lymphoma (ATLL)Preclinical
YB328 Microbiome ProgramCancer ImmunotherapyResearch

Leadership Team at ARC Therapies

渡慶
渡邊 慶介 (Keisuke Watanabe)
Director, National Cancer Center Principal Investigator
前優
前田 優香 (Yuka Maeda)
Director, National Cancer Center Unit Leader
武行
武本 行弘 (Yukihiro Takemoto)
COO
横雅
横山 雅彦 (Masahiko Yokoyama)
CFO
View full ARC Therapies profile